ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹5,004 Cr | ₹-542 Cr | ₹193 Cr | ₹-725 Cr | ₹-194 Cr |
What is the latest Total Non-Current Liabilities ratio of ZYDUS LIFESCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹5,004 Cr |
| Mar2025 | ₹-542 Cr |
| Mar2024 | ₹193 Cr |
| Mar2023 | ₹-725 Cr |
| Mar2022 | ₹-194 Cr |
How is Total Non-Current Liabilities of ZYDUS LIFESCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,004 Cr | Positive | |
| Mar2025 | ₹-542 Cr | Negative | |
| Mar2024 | ₹193 Cr | Positive | |
| Mar2023 | ₹-725 Cr | Negative | |
| Mar2022 | ₹-194 Cr | - | |
Compare Total Non-Current Liabilities of peers of ZYDUS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZYDUS LIFESCIENCES | ₹111,241.2 Cr | -0.1% | -3.9% | 14.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
ZYDUS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZYDUS LIFESCIENCES | -0.1% |
-3.9% |
14.1% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses